Recombinant 2019-nCoV(SARS-CoV-2) Spike Protein RBD L452Q mutant (lambda variant C.37 lineage)

Recombinant 2019-nCoV(SARS-CoV-2) Spike Protein RBD L452Q mutant (lambda variant C.37 lineage)
The world is in midst of the COVID-19 pandemic. SARS-CoV-2 Lambda, a new variant of interest, is now spreading in some South American countries. On June 15, 2021, the World Health Organization designated C.37 as Variant of Interest (VOI) Lambda. Two of the spike mutations are at key residues in the RBD (L452Q and F490S).
Spike Mutation in SARS-COV-2 (2019nCOV) lambda variant C.37 lineage Spike-S1 Subunit:
N Terminal G75V T76I R246N Δ247-253
Spike-RBD L452Q F490S
Spike-S1 Subunit D614G
Spike-S2 Subunit T859N
Recombinant 2019-nCoV(SARS-CoV-2) Spike Protein RBD L452Q mutant (lambda variant C.37 lineage)

The world is in midst of the COVID-19 pandemic. SARS-CoV-2 Lambda, a new variant of interest, is now spreading in some South American countries. On June 15, 2021, the World Health Organization designated C.37 as Variant of Interest (VOI) Lambda. Two of the spike mutations are at key residues in the RBD (L452Q and F490S).
Spike Mutation in SARS-COV-2 (2019nCOV) lambda variant C.37 lineage Spike-S1 Subunit:
N Terminal G75V T76I R246N Δ247-253
Spike-RBD L452Q F490S
Spike-S1 Subunit D614G
Spike-S2 Subunit T859N